Indaptus Therapeutics (INDP) Institutional Ownership → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free INDP Stock Alerts $2.34 +0.03 (+1.30%) (As of 05/20/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Indaptus Therapeutics (NASDAQ:INDP)CurrentInstitutional OwnershipPercentage7.06%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$56.05KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$34.07K Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INDP Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Indaptus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC14,232$32K0.0%N/A0.167% 11/9/2023 Investment House LLC102,849$283K0.0%-5.0%1.224% 8/25/2023 Strategy Asset Managers LLC45,336$87K0.0%-18.1%0.540% 8/8/2023 Investment House LLC108,282$207K0.0%+13.2%1.289% 10/11/2022 Strategy Asset Managers LLC55,336$120K0.0%N/A0.670% 7/22/2022 Stratos Wealth Partners LTD.26,832$70K0.0%-97.7%0.325% 4/26/2022 Stratos Wealth Partners LTD.1,188,356$4.75M0.1%-14.4%14.389% 2/9/2022 Investment House LLC95,629$545K0.0%+272.8%1.167% 1/14/2022 Stratos Wealth Partners LTD.1,388,356$7.91M0.2%N/A16.952% 11/15/2021 Marshall Wace LLP12,780$100K0.0%N/A0.236% 10/25/2021 Harel Insurance Investments & Financial Services Ltd.2,958$25K0.0%N/A0.055% (Data available from 1/1/2016 forward) INDP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INDP shares? During the previous two years, the following institutional investors and hedge funds held shares of Indaptus Therapeutics shares: Investment House LLC ($283K), Strategy Asset Managers LLC ($87K), and Stratos Wealth Partners LTD. ($70K), Virtu Financial LLC ($32K).Learn more on INDP's institutional investors. What percentage of Indaptus Therapeutics stock is owned by institutional investors? 7.06% of Indaptus Therapeutics stock is owned by institutional investors. Learn more on INDP's institutional investor holdings. Which institutional investors have been buying Indaptus Therapeutics stock? The following institutional investors have purchased Indaptus Therapeutics stock in the last 24 months: Strategy Asset Managers LLC ($55.34K), Virtu Financial LLC ($14.23K), and Investment House LLC ($12.65K). How much institutional buying is happening at Indaptus Therapeutics? Institutional investors have bought a total of 82,221 shares in the last 24 months. This purchase volume represents approximately $175.57K in transactions. Which Indaptus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Indaptus Therapeutics stock in the last 24 months: Stratos Wealth Partners LTD. ($1.16M), Strategy Asset Managers LLC ($10K), and Investment House LLC ($5.43K). How much institutional selling is happening at Indaptus Therapeutics? Institutional investors have sold a total of 1,176,957 shares in the last 24 months. This volume of shares sold represents approximately $3.07M in transactions. Related Companies: SLGL Major Shareholders AYTU Major Shareholders GLTO Major Shareholders VBIV Major Shareholders GLYC Major Shareholders KALA Major Shareholders BIVI Major Shareholders NERV Major Shareholders SYBX Major Shareholders TCRT Major Shareholders This page (NASDAQ:INDP) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.